MedTrace Logo

Effect of Pregabalin Administration on Catheter- Related Bladder Discomfort in Orthopedic Surgical Operations

NCT03232021 · Status: WITHDRAWN · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL

Last updated 2020-03-31

No results posted yet for this study

Summary

The aim of this study is to assess the effect of pregabalin administration on catheter-related bladder discomfort (CRBD). The study group includes patients that are about to be subjected to orthopedic operations.

Conditions

  • Pregabalin on Catheter Related Bladder Discomfort

Interventions

DRUG

Placebo oral capsule

Placebo oral capsule administered 1 hour prior to the surgical operation

DRUG

Pregabalin Oral Capsule [Lyrica] 75mg

Pregabalin Oral Capsule \[Lyrica\] 75 mg administered 1 hour prior to the surgical operation

DRUG

Pregabalin Oral Capsule [Lyrica] 150 mg

Pregabalin Oral Capsule \[Lyrica\] 150 mg administered 1 hour prior to the surgical operation

Sponsors & Collaborators

  • University of Thessaly

    collaborator OTHER

  • Saint Savvas Anticancer Hospital

    lead OTHER

Principal Investigators

  • Sofia Poulopoulou, Head of department · Anticancer Hospital of Athens 'Saint Savvas'

  • Eleni Arnaoutoglou, Professor of Anesthesiology · University of Thessaly, Medical School, Anesthesiology Clinic

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
45 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-08-16
Primary Completion
2018-12-31
Completion
2019-04-30

Countries

  • Greece

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03232021 on ClinicalTrials.gov